Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-behcet disease.
Hatzitolios
Apostolos
A
Savopoulos
Christos
C
Ntaios
George
G
Tsirogianni
Efrosini
E
Baltatzi
Maria
M
Apostolopoulou
Martha
M
Dimitrakoudi
Evaggelia
E
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications* / Q000503:physiopathology*; D020516:Brachial Plexus Neuropathies / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D020427:Peroneal Neuropathies / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D011241:Prednisone